Ascorbic acid and α-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines

被引:19
作者
Mooradian, AD [1 ]
Haas, MJ [1 ]
Wadud, K [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63104 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 02期
关键词
D O I
10.1016/j.metabol.2005.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HepG2 cells and Caco-2 cells were treated with various concentrations of select antioxidants to study some of the molecular pathways underlying antioxidant-related changes in apolipoprotein A-I (apoA-I) expression. Both a-tocopherol and ascorbate treatment over a time course of 72 hours caused a significant reduction in apoA-I messenger RNA and protein levels in a dose-dependent fashion. Albumin levels did not change with any treatment, suggesting that the effect is protein-specific. Similar changes were seen in Caco-2 cells. In contrast, apoA-I messenger RNA and protein levels significantly increased after 28 and 280 mu mol/L dimethyl sulfoxide (DMSO) treatment. Cells were transfected with chloramphenicol acetyltransferase (CAT) reporter gene plasmid containing the full-length apoA-I promoter to determine if these changes occur at a transcriptional level, and after 24 hours, the HepG2 or Caco-2 cells were treated with varying concentrations of ascorbate or a-tocopherol. At the highest concentration of ascorbate and a-tocopherol used (5 mmol/L), there was a significant reduction in apoA-I promoter activity. DMSO treatment up-regulated apoA-I promoter activity, whereas increasing oxidative load with 50, 100, and 200 mu mol/L hydrogen peroxide treatment did not significantly alter apoA-I promoter activity. Studies with deletional constructs of the promoter containing or lacking the antioxidant response element (ARE) indicated that the effect of ascorbate and a-tocopherol, unlike that of DMSO, was independent of this ARE. Using a series of apoA-I deletion constructs, it was shown that site A-containing segment of the promoter has a critical regulatory element. However, electromobility shift assays indicated that there was no significant change in nuclear factor binding activity to site A as a result of treatment with ascorbate or a-tocopherol. As expected, treatment with DMSO increased factor binding to the previously described ARE. It is concluded that the apoA-I promoter-stimulating effect of DMSO may be independent of its antioxidant activity and that some antioxidants at very high concentrations may have suppressive effect on the apoA-I gene expression. It appears that the inhibitory effect of ascorbate or alpha-tocopherol on the apoA-I promoter is either indirect or is the result of posttranslational modifications of the nuclear binding factors. The previously described ARE is not a response element for the ascorbate or alpha-tocopherol. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 39 条
[1]   Change in α1 HDL concentration predicts progression in coronary artery stenosis [J].
Asztalos, BF ;
Batista, M ;
Horvath, KV ;
Cox, CE ;
Dallal, GE ;
Morse, JS ;
Brown, GB ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) :847-852
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].
Brown, BG ;
Zhao, XQ ;
Chait, A ;
Fisher, LD ;
Cheung, MC ;
Morse, JS ;
Dowdy, AA ;
Marino, EK ;
Bolson, EL ;
Alaupovic, P ;
Frohlich, J ;
Albers, JJ ;
Serafini, L ;
Huss-Frechette, E ;
Wang, S ;
DeAngelis, D ;
Dodek, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592
[4]  
BURGER C, 1994, J CELL SCI, V107, P2047
[5]   Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL [J].
Cheung, MC ;
Zhao, XQ ;
Chait, A ;
Albers, JJ ;
Brown, BG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) :1320-1326
[6]  
Chomczynski P, 1987, ANAL BIOCHEM, V132, P6
[8]   Regulation of human apolipoprotein A-I gene expression by gramoxone [J].
Cuthbert, C ;
Wang, ZW ;
Zhang, X ;
Tam, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14954-14960
[9]   Relevance of the palatal protein kinase A pathway to the pathogenesis of cleft palate by secalonic acid D in mice [J].
Dhulipala, VC ;
Hanumegowda, UM ;
Balasubramanian, G ;
Reddy, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 194 (03) :270-279
[10]  
DUFOUR DR, 1995, PRINCIPLES PRACTICE, P1957